Clinical Trial Update: Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas [Phase 2]

View source ↗

Summary

Phase 2 trial update on radioactive iodine implants for pituitary macroadenomas (termed pan-invasive), with terminated status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Macroadenoma

Drugs mentioned

• radioactive iodine implants

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Pituitary Macroadenoma | Phase 2 | Status: TERMINATED | Results posted: 2021-11-30